Latest Insider Transactions at Next Cure, Inc. (NXTC)
This section provides a real-time view of insider transactions for Next Cure, Inc. (NXTC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NextCure, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NextCure, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
350,000
+11.43%
|
$5,250,000
$15.0 P/Share
|
|
May 13
2019
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,361,013
+32.95%
|
-
|
|
May 13
2019
|
Canaan X L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+2.17%
|
$750,000
$15.0 P/Share
|
|
May 13
2019
|
Canaan X L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,204,442
+31.87%
|
-
|